Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-453
TNBC
Luminal
PD184352
MEK
MAPK
12414.155
uM
39.26240
41.19550
0.6846 -0.1173 4.3855 0.0557
0.5773
1.2420
MDA-MB-453
TNBC
Luminal
PD184352
MEK
MAPK
12414.155
uM
39.26240
41.19550
0.6846 -0.1173 4.3855 0.0557
0.5773
1.2420
MDA-MB-453
TNBC
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7517.095
uM
inf
inf
0.6190 0.6190 0.0000 0.4058
0.0000
1.5365
MDA-MB-453
TNBC
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7518.095
uM
inf
inf
0.8558 0.8558 0.0000 0.0847
0.0759
1.4438
MDA-MB-453
TNBC
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7515.095
uM
inf
inf
0.4487 0.4487 0.0000 0.4056
0.3245
0.9628
MDA-MB-453
TNBC
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7516.095
uM
inf
inf
0.1417 0.1417 0.0000 0.2650
0.3783
1.3423
MDA-MB-453
TNBC
Luminal
PS-1145
IKK
NFKB
7518.065
uM
inf
inf
0.9324 0.9324 0.0000 -0.0310
-0.1509
1.3677
MDA-MB-453
TNBC
Luminal
PS-1145
IKK
NFKB
7515.065
uM
inf
inf
0.7626 0.7626 0.0000 0.1588
0.0295
1.3234
MDA-MB-453
TNBC
Luminal
PS-1145
IKK
NFKB
7516.065
uM
inf
inf
0.8456 0.8456 0.0000 0.0909
0.0484
1.3224
MDA-MB-453
TNBC
Luminal
PS-1145
IKK
NFKB
7517.065
uM
inf
75.32750
0.8491 0.8330 0.5724 0.0481
0.7757
1.5040
MDA-MB-453
TNBC
Luminal
Purvalanol A
CDK1
CDK
7518.067
uM
inf
inf
0.8749 0.8749 0.0000 0.2698
-0.1447
0.7666
MDA-MB-453
TNBC
Luminal
Purvalanol A
CDK1
CDK
7517.067
uM
inf
2.62770
0.9085 0.8391 4.6694 0.0251
0.5929
1.3778
MDA-MB-453
TNBC
Luminal
Ribavirin
15398.211
uM
inf
inf
0.8982 0.8982 0.0000 0.0145
0.1417
1.0628
MDA-MB-453
TNBC
Luminal
SB-3CT
MMP2/9
MMP
12414.168
uM
inf
4.03070
0.5643 0.6238 1.6484 0.1458
0.8451
1.2069
MDA-MB-453
TNBC
Luminal
Selumetinib
MEK
MAPK
12414.155
uM
inf
4.06690
0.7350 0.7375 5.0000 0.0483
0.8704
1.2420
MDA-MB-453
TNBC
Luminal
Sigma A6730
AKT
AKT
12414.165
uM
1.99070
4.41480
-0.9516 -1.0000 1.3794 0.4333
0.9973
1.2459
MDA-MB-453
TNBC
Luminal
Sirolimus
MTOR
MTOR
7518.069
uM
0.07350
0.03663
0.1491 0.1266 0.4191 0.4555
0.9895
1.5543
MDA-MB-453
TNBC
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7517.084
uM
inf
inf
0.8484 0.8484 0.0000 0.1100
-0.0346
1.4076
MDA-MB-453
TNBC
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7518.084
uM
inf
14.81730
0.5714 0.5599 4.9933 0.1318
0.8275
1.3244
MDA-MB-453
TNBC
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7517.067
uM
inf
inf
-0.9439 -0.9439 0.0000 0.3480
0.4207
1.3778
MDA-MB-453
TNBC
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7518.067
uM
5.55180
6.91490
-0.9997 -0.9988 5.0000 0.5773
0.8581
0.7666
MDA-MB-453
TNBC
Luminal
Taxol
TUBB
TUBB
7903.002
uM
0.00625
0.00804
-0.5025 -0.4695 2.6296 0.9842
0.9884
1.2202
MDA-MB-453
TNBC
Luminal
Taxol
TUBB
TUBB
9708.002
uM
0.00970
0.01172
-0.2544 -0.1950 1.7464 0.7160
0.9893
1.0482
MDA-MB-453
TNBC
Luminal
Taxol
TUBB
TUBB
12964.002
uM
0.00864
0.01139
-0.5617 -0.5234 2.5980 0.9297
0.9952
0.5925
MDA-MB-453
TNBC
Luminal
Taxol
TUBB
TUBB
9723.002
uM
0.01302
0.01943
-0.4095 -0.4017 1.4740 0.8003
0.9958
0.8443